Nina Ivanovska Selected Research

Nina Ivanovska Research Topics

Disease

11	Inflammation (Inflammations) 01/2016 - 06/2003
9	Arthritis (Polyarthritis) 05/2020 - 11/2006
6	Osteoarthritis 06/2023 - 03/2011
5	Infections 08/2014 - 06/2004
3	Osteophyte 05/2020 - 03/2011
3	Rheumatoid Arthritis 10/2017 - 07/2006
3	Sepsis (Septicemia) 01/2016 - 08/2014
3	Shock 03/2015 - 11/2008
2	Bone Resorption 05/2020 - 03/2011
2	Bacterial Infections (Bacterial Infection) 06/2016 - 08/2014
2	Liver Diseases (Liver Disease) 03/2015 - 11/2008
2	Body Weight (Weight, Body) 05/2009 - 11/2008
1	Synovitis 10/2017
1	Neoplasms (Cancer) 06/2016
1	Endotoxemia 01/2016
1	Communicable Diseases (Infectious Diseases) 08/2014
1	Pneumonia (Pneumonitis) 08/2014
1	Listeriosis (Listeria Infection) 08/2014
1	Autoimmune Diseases (Autoimmune Disease) 08/2014
1	Proteinuria 05/2009
1	Multiple Organ Failure (MODS) 11/2008
1	Renal Insufficiency (Renal Failure) 11/2008
1	Reinfection 11/2006
1	Experimental Arthritis 07/2006
1	Human Influenza (Influenza) 03/2006
1	Candidiasis (Moniliasis) 02/2005
1	Hypersensitivity (Allergy) 01/2002

Drug/Important Bio-Agent (IBA)

8	ZymosanIBA 10/2017 - 06/2007
6	Collagenases (Collagenase)FDA Link 01/2021 - 03/2011
6	CytokinesIBA 05/2020 - 05/2009
4	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 03/2015 - 11/2008
3	Tyrosine Kinase InhibitorsIBA 03/2015 - 11/2008
3	TyrphostinsIBA 03/2015 - 11/2008
3	ProperdinIBA 08/2014 - 04/2010
3	CollagenIBA 07/2012 - 06/2004
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 02/2005
2	Complement System Proteins (Complement)IBA 10/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 06/2016 - 05/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2016 - 01/2002
2	LigandsIBA 01/2014 - 05/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2014 - 01/2014
2	Toll-Like Receptor 2IBA 01/2014 - 01/2014
2	Proteoglycans (Proteoglycan)IBA 03/2011 - 04/2010
2	CreatinineIBA 05/2009 - 11/2008
2	Leflunomide (Arava)FDA LinkGeneric 11/2006 - 07/2006
1	Biomarkers (Surrogate Marker)IBA 06/2023
1	Nicotinamide PhosphoribosyltransferaseIBA 06/2023
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2023
1	Metformin (Glucophage)FDA LinkGeneric 06/2023
1	Hormones (Hormone)IBA 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2020
1	Estrogens (Estrogen)FDA Link 05/2020
1	Sudan Black BIBA 10/2017
1	A-factor (Streptomyces)IBA 10/2017
1	TNF-Related Apoptosis-Inducing LigandIBA 06/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016
1	glaucineIBA 02/2015
1	Janus KinasesIBA 08/2014
1	Antineoplastic Agents (Antineoplastics)IBA 08/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014
1	InterleukinsIBA 01/2014
1	Combined Antibody TherapeuticsIBA 07/2012
1	Glucosamine (Dona)IBA 03/2011
1	GlycosaminoglycansIBA 03/2011
1	Chemokine CCL5IBA 05/2009
1	Interleukin-10 (Interleukin 10)IBA 05/2009
1	Chemokine CCL3IBA 05/2009
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2008
1	Alanine Transaminase (SGPT)IBA 11/2008
1	dicyanmethane (malononitrile)IBA 11/2008
1	BilirubinIBA 11/2008
1	Indicators and Reagents (Reagents)IBA 11/2008
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 06/2007
1	Interleukin-4 (Interleukin 4)IBA 07/2006
1	Oxidoreductases (Dehydrogenase)IBA 07/2006
1	Immunoglobulin FragmentsIBA 03/2006
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 03/2006
1	Peptides (Polypeptides)IBA 03/2006
1	Complement Receptors (Complement Receptor)IBA 03/2006
1	Hemagglutinins (Hemagglutinin)IBA 03/2006
1	AntibodiesIBA 06/2004
1	Collagen Type II (Type II Collagen)IBA 06/2003

Therapy/Procedure

2	Intraperitoneal Injections 07/2012 - 05/2009
1	Injections 02/2015
1	Therapeutics 01/2014
1	Intra-Articular Injections 01/2014